Why chains such as Chipotle and Chili’s could have a better 2026 than their rivals

UBS analysts say new tax breaks and a lower bar to clear could make 2026 more…

Novo Nordisk’s weight-loss pill is available. Here’s why Lilly’s and Viking’s stocks are down.

Novo Nordisk’s wildly successful obesity medicine is now available as a pill, making it the first…

Rising prices and weight-loss drugs are changing the way we eat — and food companies are racing to keep up

A shaky economy, wider adoption of weight-loss drugs, and changing tastes seem to conspire against some…

Novo Nordisk first out of the gate with oral weight-loss drug, and its stock jumps

Relief rally underway in Novo Nordisk after a difficult year for the stock which saw it…

Eli Lilly’s newest weight-loss drug relieved pain in patients with knee osteoarthritis

Published: Dec. 11, 2025 at 7:55 a.m. ET One of Eli Lilly’s most promising new obesity drugs…

Structure Therapeutics details positive trial data for a weight-loss pill, and the stock rockets

Published: Dec. 8, 2025 at 9:12 a.m. ET Structure Therapeutics’ stock soared toward an 18-month high in…

Trump rolls out pricing deal with weight-loss-drug giants Eli Lilly, Novo Nordisk. Analysts say the pact raises more questions than it answers.

Jessica Hall is a retirement reporter for MarketWatch. She was an Age Boom Academy Fellow with…

Medicare recipients may get obesity drugs for just $149 a month under a reported White House deal in the works

The White House is close to announcing a deal with drugmakers Eli Lilly and Novo Nordisk…